References
- Agarwal M, Parameswari RP, Vasanthi HR, Das DK. Dynamic action of carotenoids in cardioprotection and maintenance of cardiac health. Molecules. 2012. 17: 4755-4769. https://doi.org/10.3390/molecules17044755
- Arango DG, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014. 8: 319.
- Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res. 2008. 22: 709-724. https://doi.org/10.1002/ptr.2362
-
Baker RG, Hayden MS, Ghosh S. NF-
${\kappa}B$ , inflammation, and metabolic disease. Cell Metab. 2011. 13: 11-22. https://doi.org/10.1016/j.cmet.2010.12.008 - Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 2005. 78: 431-441. https://doi.org/10.1016/j.lfs.2005.09.012
- Blasius AL, Beutler B. Intracellular toll-like receptors. Immunity. 2010. 32: 305-315. https://doi.org/10.1016/j.immuni.2010.03.012
- Chen RH, Juo PC, Curran T, Blenis J. Phosphorylation of c-Fos at the C-terminus enhances its transforming activity. Oncogene. 1996. 12: 1493-1502.
-
Chun J, Choi RJ, Khan S, Lee DS, Kim YC, Nam YJ, Lee DU, Kim YS. Alantolactone suppresses inducible nitric oxide synthase and cyclooxygenase-2 expression by down-regulating NF-
${\kappa}B$ , MAPK and AP-1 via the MyD88 signaling pathway in LPS-activated RAW 264.7 cells. Int Immunopharmacol. 2012. 14: 375-383. https://doi.org/10.1016/j.intimp.2012.08.011 - Di Lorenzo C, Dell'Agli M, Badea M, Dima L, Colombo E, Sangiovanni E, Restani P, Bosisio E. Plant food supplements with anti-inflammatory properties: a systematic review (II). Crit Rev Food Sci Nutr. 2013. 53: 507-516. https://doi.org/10.1080/10408398.2012.691916
-
Dinarello CA. A clinical perspective of IL-
$1{\beta}$ as the gatekeeper of inflammation. Eur J Immunol. 2011. 41: 1203-1217. https://doi.org/10.1002/eji.201141550 - Gilroy D, De Maeyer R. New insights into the resolution of inflammation. Semin Immunol. 2015. 27: 161-168. https://doi.org/10.1016/j.smim.2015.05.003
- Guina T, Biasi F, Calfapietra S, Nano M, Poli G. Inflammatory and redox reactions in colorectal carcinogenesis. Ann N Y Acad Sci. 2015. 1340: 95-103. https://doi.org/10.1111/nyas.12734
- Hartman J, Frishman WH. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev. 2014. 22: 147-151. https://doi.org/10.1097/CRD.0000000000000021
- Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of Licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin. Regul Toxicol Pharmacol. 2006. 46: 167-192. https://doi.org/10.1016/j.yrtph.2006.06.002
- Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene. 2001. 20: 2401-24112. https://doi.org/10.1038/sj.onc.1204389
- Kao TC, Wu CH, Yen GC. Bioactivity and potential health benefits of licorice. J Agric Food Chem. 2014. 62: 542-553. https://doi.org/10.1021/jf404939f
- Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005. 1754: 253 -262. https://doi.org/10.1016/j.bbapap.2005.08.017
- Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006. 13: 816 -825. https://doi.org/10.1038/sj.cdd.4401850
- Kim SJ, Kim CG, Yun SR, Kim JK, Jun JG. Synthesis of licochalcone analogues with increased anti-inflammatory activity. Bioorg Med Chem Lett. 2014. 24: 181-185. https://doi.org/10.1016/j.bmcl.2013.11.044
- Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002. 105: 1135-1143. https://doi.org/10.1161/hc0902.104353
- O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 2007. 7: 353-364. https://doi.org/10.1038/nri2079
- Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signaling: implications for inflammatory diseases. Nat Rev Immunol. 2009. 9: 778-788. https://doi.org/10.1038/nri2655
- Pulverer BJ1, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature. 1991. 353: 670-674. https://doi.org/10.1038/353670a0
- Schonthaler HB, Guinea-Viniegra J, Wagner EF. Targeting inflam-mation by modulating the Jun/AP-1 pathway. Ann Rheum Dis. 2011. 70 Suppl: 109-112. https://doi.org/10.1136/ard.2010.140533
- Smith AM, Sewell GW, Levine AP, Chew TS, Dunne J, O'Shea NR, Smith PJ, Harrison PJ, Macdonald CM, Bloom SL, Segal AW. Disruption of macrophage pro-inflammatory cytokine release in Crohn's disease is associated with reduced optineurin expression in a subset of patients. Immunology. 2015. 144: 45-55. https://doi.org/10.1111/imm.12338
- Snelten CS, Dietz B, Bolton JL. Modulation of estrogen chemical carcinogenesis by botanical supplements used for postmenopausal women's health. Drug Discov Today Dis Mech. 2012. 9: 47-54. https://doi.org/10.1016/j.ddmec.2012.11.001
- Wisdom R. AP-1: one switch for many signals. Exp Cell Res. 1999. 253: 180-185. https://doi.org/10.1006/excr.1999.4685
- Xiao JB, Hogger P. Dietary polyphenols and type 2 diabetes: current insights and future perspectives. Curr Med Chem. 2015. 22: 23-38.
- Zenz R, Eferl R, Scheinecker C, Redlich K, Smolen J, Schonthaler HB, Kenner L, Tschachler E, Wagner EF. Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res Ther. 2008. 10: 201.